Device shows potential in preventing stroke by blocking clots

10/3/2013 | Charleston Regional Business Journal (S.C.)

PMG Research is conducting a clinical trial comparing the effectiveness of St. Jude Medical's Amplatzer cardiac plug, an anti-clotting device, to anticoagulant therapy. The device is inserted into a patient's leg via catheter and blocks part of the heart to keep clots from flowing into the bloodstream. Researcher Dr. Matthew O'Steen said the Amplatzer shows promise in stroke prevention.

View Full Article in:

Charleston Regional Business Journal (S.C.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA